Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
US Department of Justice
McKinsey
Citi
Boehringer Ingelheim
Fuji
Cipla
Express Scripts
Chinese Patent Office
Healthtrust

Generated: August 18, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: mesalamine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAKAISER FOUNDATION HOSPITALS0179-0142-7030 TABLET, DELAYED RELEASE in 1 BOX, UNIT-DOSE (0179-0142-70)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-01120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-0212 BOTTLE in 1 CARTON (54092-476-02) > 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-083 CARTON in 1 CARTON (54092-476-08) > 8 BLISTER PACK in 1 CARTON > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-12120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-12)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
Fish and Richardson
Queensland Health
Accenture
Chubb
Colorcon
Chinese Patent Office
Moodys
Julphar

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot